Free Trial

Dr. Martens Interim Earnings Report

Dr. Martens logo
GBX 70.48 +1.98 (+2.89%)
As of 12:00 PM Eastern

Dr. Martens EPS Results

Actual EPS
-GBX 1.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Dr. Martens Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Dr. Martens Announcement Details

Quarter
Interim
Time
Before Market Opens

Conference Call Resources

Dr. Martens Earnings Headlines

Dr. Martens creative director steps down after a decade
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
See More Dr. Martens Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Dr. Martens? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dr. Martens and other key companies, straight to your email.

About Dr. Martens

Dr. Martens (LON:DOCS) is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index. Dr. Martens operates across three geographic regions: EMEA, Americas and APAC. Our product segments include Originals, Fusion, Kids and Casual and a complementary range of Accessories.

View Dr. Martens Profile

More Earnings Resources from MarketBeat